本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

和黃醫藥

13.76
+0.02000.15%
盤後13.760.00000.00%16:05 EDT
成交量:3.42萬
成交額:47.13萬
市值:23.53億
市盈率:68.80
高:13.98
開:13.78
低:13.71
收:13.74
資料載入中...
2020/07/06

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/04/29

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/03

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/03

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/21

SEC問詢函

CORRESP [Cover] - Correspondence
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/29

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/15

SEC問詢函

CORRESP [Cover] - Correspondence